The healthcare sector is responsible for 4-6% of global carbon emissions. At Fortrea, we understand that sustainability in clinical trials has the potential to deliver improved performance. Read on to find out how. #sustainablestudies
About us
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.
- Website
-
https://fortrea.com
External link for Fortrea
- Industry
- Hospitals and Health Care
- Company size
- 10,001 employees
- Headquarters
- Durham, North Carolina
- Type
- Public Company
Locations
-
Primary
8 Moore Dr
Durham, North Carolina 27709, US
Employees at Fortrea
-
Alan Switzer
Clinical systems and process specialist | Digital transformation expert | Collaborative partner | Client Engagement Leader at Fortrea.
-
Linda Watkins
I have finally found my professional home!
-
Miroslaw (Mirek) Dudek
Associate Director, Change Management at Fortrea
-
Robert Boman
Global Creative Director | Team Builder | Omni-channel Storyteller | BBQ Snob
Updates
-
Triple-negative breast cancer (TNBC) remains a formidable challenge due to its aggressive nature. While immunotherapy has shown promise in metastatic settings, its role in early-stage TNBC is less defined. Window-of-opportunity (WOO) trials have explored the potential benefits of immunotherapy before surgery or standard chemotherapy. These studies offer insights into de-escalating treatment regimens without compromising patient outcomes. To learn more about the implications of WOO trials and potential de-escalation strategies, please read this open-access article in ESMO Open, written by Fortrea oncologists in collaboration with academic KOLs: https://lnkd.in/eDh_fUBg Kamal S. Saini, Laura Vidal Boixader
-
Join us at BioJapan 2024 in Yokohama from October 9-11! Visit us at Booth D-9 and don't miss our joint seminar with our strategic partner, Beyond Next Ventures, Japan. 📅 Mark your calendars for Friday, October 11, 2024, from 12:05-12:35 p.m. at Presentation Stage B, Pacific Convention Plaza Yokohama. 🎤 Seminar Topic: Accessing Global Markets and Regulators from Japan’s Innovative Biopharma Sector Learn how our collaboration is bridging the gap between local and global markets, empowering Japanese startups to make a significant impact worldwide. Don't miss this opportunity to connect with us and discover how we can support your biopharma journey. 🌍💊 https://lnkd.in/efVkn4DC #BioJapan2024 #Biopharma #GlobalMarkets #biotech #BNVJapan #PharmaceuticalEcosystem
-
At this year's Xcellerate Strategic Advisory Group Meeting in Raleigh, NC, team members and participants from GlobalLogic, CSL Behring, and more, shared their insights, experiences and feedback of Fortrea's Xcellerate platform. This year's agenda is designed to inspire while unveiling our overarching technology vision and how Xcellerate will help. https://lnkd.in/eMP59zqT #pharma #cro #clinicalresearch
-
The finalists are in! Congratulations to the six Forteans who made the running for the top honors in the 2024 Clinical Researcher of the Year-The Americas! Each year, PharmaTimes hosts regional competitions to recognize clinical researchers around the world in its Clinical Researcher of the Year competition. It’s demanding and the judging is rigorous. Only top talent makes it. We’ll be sitting on the edge of our seats for news on 21 October when the winners will be announced. Here are the finalists who will be representing Fortrea: • Clinical Trial Manager: Emily Gee • Novice CRA: Katelyn Hester • Intermediate CRA: Ellie Lorenz • Experienced CRA: Brent Gregory • Global Project Manager: Stephanie Santos-Díaz • Global Project Manager: Aruna Govindaraju https://lnkd.in/gPzwbmX4
-
Fortrea’s MPSS team shares insights on achieving GDP and GMP compliance, navigating regulatory challenges, and streamlining product life cycle management. 📄 Learn more in our blog: https://lnkd.in/ev22-Juj #ProductManagement #Documentation #Compliance #Pharma #PersonalCare #Fortrea #MPSS #GDP #GMP #RegulatoryCompliance #SupplyChain #ProductLifeCycle
-
At this year's Xcellerate Strategic Advisory Group Meeting in Raleigh, NC, team members and participants from Merck and other pharmaco's shared their insights, positive experiences and feedback based on their use of Xcellerate while working with Fortrea. This year's agenda is designed to inspire while unveiling our overarching technology vision and how Xcellerate will help. Shout out to Mark Morais, Troy Bryenton, and Steven Lang CPM, PMP, PPMC, MBA for cheering on the interactive sessions. https://lnkd.in/eMP59zqT #pharma #cro #clinicalresearch
-
Congratulations to Fortrea's Dr. Deepak Kallubundi CCDM®, CPM on winning the #SCDM 2024 Volunteer Project of the Year award and for all your contributions to #ClinicalDataManagement. 🎉
We're thrilled to announce that the #SCDM 2024 Volunteer Project of the Year goes to ...🥁, Dr. Deepak Kallubundi CCDM®, CPM and Kelly Chelnik MPH, CCDM for leading one of the most significant projects of this year - the Clinical Data Associate Beta Exam. Their effort, commitment and dedication have been crucial in the creation of the new certification program - Certified Clinical Data Associate (CCDA). 🙏 Thank you for your contributions and paving the way for brighter future in #CinicalDataManagement! #SCDM24 #SCDMAwards
-
🌍 Global Diversity Awareness Month 🌍 is a celebration of the incredible impact that a diverse culture can have on our society. At Fortrea, we take immense pride in our global diversity. In today’s interconnected world, our collective differences enable us to bridge gaps and create meaningful change. Whether you enjoy a cup of kaffe or 咖啡, play soccer or fútbol, or dance bharatanatyam or waltz, Fortreans around the world learn from each other and share their unique perspectives. Together, we are stronger and more innovative. Discover more about our commitment to diversity in our latest CSR report. https://lnkd.in/eGVTGA55 #GlobalDiversityAwarenessMonth #InclusionMatters #CelebrateDiversity #DiversityAndInclusion #TogetherWeThrive #GlobalUnity #EmbraceDifferences #OneWorldManyCultures
-
We're thrilled to announce that our team of Vikas Mohan Sharma, Tetyana Korchak, and Laurentiu Gutiu, MD will be participating in the 17th Clinical Trials on Alzheimer's Disease (CTAD), 29 Oct-01 Nov in Madrid, Spain. Neurodegenerative diseases represent some of the most challenging trials. Start the conversation now by reading our latest thought leadership piece on patient and site centricity in neurodegenerative clinical trials. Want to connect in person? Let’s schedule a meeting during the event to discuss how we can collaborate to advance innovation in neuroscience clinical studies. https://lnkd.in/etcJJG2b #CTAD24 #neuroscience #clinicaltrials #neurodegenrativedisease #thoughtleadeship #letsinnovatetogether #patientcentricity #sitecentricity